| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
JPAG - PAST MEETINGS
RETURN TO MEETINGS
Thursday 12th May 2016
Sterility assurance best practice for aseptically manufactured products
Royal Society of Chemistry, London
Purpose of meeting
The purpose of the meeting is to deliver a best practice forum of like-minded professionals engaged in the manufacture of aseptic pharmaceutical products. JPAG have assembled a strong line up of opinion leaders and experts from the UK regulator, the MHRA, industry and the NHS in the field of aseptic manufacture and microbiological monitoring and testing to provide an excellent opportunity for networking and bench marking for delegates. The meeting will also play host to equipment providers to show the current state of the art in aseptic manufacturing and testing equipment.
Challenge
The aseptic manufacturing community has the continuing challenge of maintaining sterility assurance levels and meeting current regulatory expectations and guidelines in order to protect the patient. Failure to comply results in severe consequences and possibly the death of a patient.
Opportunities
As regulations evolve and new technologies develop, the pace of change varies in the industry. Attendance at this meeting will offer delegates the opportunity of learning from opinion leaders, regulators and delegates implementing best practice in the challenge of production of aseptic medicinal products.
Proposed outcomes
Sharing of best practice, bringing delegates up to date with current regulatory expectations and viewing state of the art equipment and a great opportunity to network and share experiences with like-minded individuals engaged in the manufacture and testing of aseptically manufactured medicinal products.
Registration commences at 09.30h and the symposium starts at 10.00h.
JPAG gratefully acknowledge the Silver sponsorship of Cherwell Laboratories for its support of this symposium.
Speakers:
James Drinkwater - Pharmaceutical and Healthcare Sciences Society
Dawn Hiles - Newcastle Cellular Therapies Facility, International Centre for Life
Andrew Hopkins - Expert GMDP Inspector, MHRA
Dr Aileen Hume - AMRI
Yan Hunter-Blair - Newcastle upon Tyne NHS Foundation Trust
Dr Paul Newby - GlaxoSmithKline
Dr Tim Sandle - Pharmaceutical Microbiology Interest Group (Pharmig)
Sterility assurance best practice for aseptically manufactured products
Royal Society of Chemistry, London
Purpose of meeting
The purpose of the meeting is to deliver a best practice forum of like-minded professionals engaged in the manufacture of aseptic pharmaceutical products. JPAG have assembled a strong line up of opinion leaders and experts from the UK regulator, the MHRA, industry and the NHS in the field of aseptic manufacture and microbiological monitoring and testing to provide an excellent opportunity for networking and bench marking for delegates. The meeting will also play host to equipment providers to show the current state of the art in aseptic manufacturing and testing equipment.
Challenge
The aseptic manufacturing community has the continuing challenge of maintaining sterility assurance levels and meeting current regulatory expectations and guidelines in order to protect the patient. Failure to comply results in severe consequences and possibly the death of a patient.
Opportunities
As regulations evolve and new technologies develop, the pace of change varies in the industry. Attendance at this meeting will offer delegates the opportunity of learning from opinion leaders, regulators and delegates implementing best practice in the challenge of production of aseptic medicinal products.
Proposed outcomes
Sharing of best practice, bringing delegates up to date with current regulatory expectations and viewing state of the art equipment and a great opportunity to network and share experiences with like-minded individuals engaged in the manufacture and testing of aseptically manufactured medicinal products.
Registration commences at 09.30h and the symposium starts at 10.00h.
JPAG gratefully acknowledge the Silver sponsorship of Cherwell Laboratories for its support of this symposium.
Speakers:
James Drinkwater - Pharmaceutical and Healthcare Sciences Society
Dawn Hiles - Newcastle Cellular Therapies Facility, International Centre for Life
Andrew Hopkins - Expert GMDP Inspector, MHRA
Dr Aileen Hume - AMRI
Yan Hunter-Blair - Newcastle upon Tyne NHS Foundation Trust
Dr Paul Newby - GlaxoSmithKline
Dr Tim Sandle - Pharmaceutical Microbiology Interest Group (Pharmig)
GET THE REPORT FOR THIS EVENT?
We will send it to you.
We will send it to you.
RETURN TO MEETINGS
WANT TO SEE MORE?
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
PAST MEETINGS
Symposium - October 2011
Delegates at a symposium held at the Royal Pharmaceutical Society
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| Joint Pharmaceutical Analysis Group 2024 Website © and by Delta Consultancy Services |
|